Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 4/20 | 0.37 |
| ▸ | DHODH | Q02127 | 8/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.30 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4491599 | 1.00 | FABP4 (0.37) | FABP4DHODHTSHRACLYCYSLTR2 | |
| SCHEMBL4491596 | 1.00 | FABP4 (0.37) | FABP4DHODHTSHRACLYCYSLTR2 | |
| SCHEMBL6002124 | 0.84 | FABP4 (0.37) | FABP4DHODHTSHRACLYCYSLTR2 | |
| SCHEMBL6002119 | 0.84 | FABP4 (0.37) | FABP4DHODHTSHRACLYCYSLTR2 | |
| SCHEMBL4516114 | 0.79 | CNR2 (0.43) | DHODHTSHR | |
| SCHEMBL4516119 | 0.79 | CNR2 (0.43) | DHODHTSHR | |
| SCHEMBL4516121 | 0.79 | CNR2 (0.43) | DHODHTSHR | |
| SCHEMBL4516304 | 0.71 | ACACB (0.34) | TSHRHPGD | |
| SCHEMBL4511261 | 0.70 | LTB4R (0.46) | FABP4TSHRHPGD | |
| SCHEMBL4511259 | 0.70 | LTB4R (0.46) | FABP4TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638540-B2 | Benzofuran compound and medicinal composition containing the same | THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7638540-B2 | Benzofuran compound and medicinal composition containing the same | THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7638540-B2 | Benzofuran compound and medicinal composition containing the same | THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) | 2009-12-29 | — | — | US | disclosed |
| US-20060194851-A1 | Benzofuran compound and medicinal composition containing the same | NEW INDUSTRY RESEARCH ORGANIZATION, THE (JP) | 2006-08-31 | — | — | US | disclosed |
| EP-1627873-A1 | BENZOFURAN COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME | The New Industry Research Organization (JP) | 2006-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194851-A1 | Benzofuran compound and medicinal composition containing the same | LTB4R2, LTC4S, LTB4R | FABP4 747/4885DHODH 789/4885TSHR 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.